14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson’s disease
Authors:
- 1 October 2015
- journal article
- Published by Elsevier in Neuroscience
- Vol. 307, 73-82
Abstract
No abstract availableKeywords
Funding Information
- Center for Clinical and Translational Science (5UL1 RR025777)
- National Institute of Neurological Disorders and Stroke (K08 NS060948)
This publication has 47 references indexed in Scilit:
- Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanismsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Specification of 14‐3‐3 proteins in Lewy bodiesAnnals of Neurology, 2003
- 14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller–Dieker syndromeNature Genetics, 2003
- Mitoxantrone Mediates Demethylation and Re-Expression of Cyclin D2, Estrogen Receptor 14.3.3 Sigma In Breast Cancer CellsCancer Biology & Therapy, 2003
- Monomeric 14-3-3 Protein Is Sufficient to Modulate the Activity of the Drosophila Slowpoke Calcium-dependent Potassium ChannelJournal of Biological Chemistry, 2003
- 14-3-3 Proteins in Lewy Bodies in Parkinson Disease and Diffuse Lewy Body Disease BrainsJournal of Neuropathology & Experimental Neurology, 2002
- 14-3-3 Proteins Mediate an Essential Anti-apoptotic SignalJournal of Biological Chemistry, 2001
- Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancerProceedings of the National Academy of Sciences, 2000
- Stimulus-Coupled Interaction of Tyrosine Hydroxylase with 14-3-3 ProteinsBiochemistry, 1999